Evidence map›Paper›PMID 30395612›Full record

ArticlePloS one2018

Approaches to variant discovery for conifer transcriptome sequencing.

Emily Telfer, Natalie Graham, Lucy Macdonald, Shane Sturrock, Phillip Wilcox, Lisa Stanbra

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emily TelferNew Zealand Forest Research Institute LTD. trading as Scion, Rotorua, New Zealand.ORCID 0000-0001-5269-6589
Natalie GrahamNew Zealand Forest Research Institute LTD. trading as Scion, Rotorua, New Zealand.
Lucy MacdonaldNew Zealand Forest Research Institute LTD. trading as Scion, Rotorua, New Zealand.
Shane SturrockNew Zealand Forest Research Institute LTD. trading as Scion, Rotorua, New Zealand.
Phillip WilcoxDepartment of Mathematics and Statistics, University of Otago, Dunedin, New Zealand.
Lisa StanbraNew Zealand Forest Research Institute LTD. trading as Scion, Rotorua, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a wide diversity of bioinformatic tools available for the assembly of next generation sequence and subsequence variant calling to identify genetic markers at scale. Integration of genomics tools such as genomic selection, association studies, pedigree analysis and analysis of genetic diversity, into operational breeding is a goal for New Zealand's most widely planted exotic tree species, Pinus radiata. In the absence of full reference genomes for large megagenomes such as in conifers, RNA sequencing in a range of genotypes and tissue types, offers a rich source of genetic markers for downstream application. We compared nine different assembler and variant calling software combinations in a single transcriptomic library and found that Single Nucleotide Polymorphism (SNPs) discovery could vary by as much as an order of magnitude (8,061 SNPs up to 86,815 SNPs). The assembler with the best realignment of the packages trialled, Trinity, in combination with several variant callers was then applied to a much larger multi-genotype, multi-tissue transcriptome and identified 683,135 in silico SNPs across a predicted 449,951 exons when mapped to the Pinus taeda ver 1.01e reference.

Indexed as

Sequence Analysis, RNAGenotypePolymorphism, Single NucleotideRNA, PlantSoftwareTranscriptomeRNA, Plant

Identifiers

PMID30395612
PMCPMC6218030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.